Literature DB >> 3027844

Degenerative changes in fungi after itraconazole treatment.

M Borgers, M A Van de Ven.   

Abstract

Changes in morphogenetic behavior and structural degeneration after exposure to itraconazole are illustrated in Candida albicans, Cryptococcus neoformans, Pityrosporum ovale, Paracoccidioides brasiliensis, Trichophyton rubrum, and Aspergillus fumigatus. With the exception of P. ovale, primary alterations are seen at the cell periphery and the cytoplasmic vacuoles in which lipid-like vesicles assemble. These changes are usually accompanied by a marked increase in cell volume, impaired cell division, or abortive hyphal outgrowth. The concentration of itraconazole necessary to induce irreversible structural degeneration (necrosis) depends greatly on the species used, the time of incubation, and the morphogenetic form in which the fungus is grown and varies from 10(-10) M (P. brasiliensis) to greater than 10(-6) M (C. albicans). Itraconazole achieves these effects either at a concentration comparable to that required for ketoconazole (C. albicans and C. neoformans); at concentrations 10- to 100-fold lower (P. ovale, T. rubrum, P. brasiliensis), or at concentrations 100-fold lower (A. fumigatus).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027844     DOI: 10.1093/clinids/9.supplement_1.s33

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  15 in total

1.  High-dose itraconazole in the treatment of severe mycoses.

Authors:  P K Sharkey; M G Rinaldi; J F Dunn; T C Hardin; R J Fetchick; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

2.  Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasis.

Authors:  J H Rex; P W Nelson; V L Paetznick; M Lozano-Chiu; A Espinel-Ingroff; E J Anaissie
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

Review 3.  Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.

Authors:  M Haria; H M Bryson; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

4.  Comparative study of four antifungal drugs in an experimental model of murine cryptococcosis.

Authors:  A J Bava; C Iovannitti; R Negroni
Journal:  Mycopathologia       Date:  1989-11       Impact factor: 2.574

Review 5.  Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses.

Authors:  S M Grant; S P Clissold
Journal:  Drugs       Date:  1989-03       Impact factor: 9.546

6.  Mechanism of action of efinaconazole, a novel triazole antifungal agent.

Authors:  Yoshiyuki Tatsumi; Maria Nagashima; Toshiyuki Shibanushi; Atsushi Iwata; Yumi Kangawa; Fumie Inui; William J Jo Siu; Radhakrishnan Pillai; Yayoi Nishiyama
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

Review 7.  Paracoccidioidomycosis: an update.

Authors:  E Brummer; E Castaneda; A Restrepo
Journal:  Clin Microbiol Rev       Date:  1993-04       Impact factor: 26.132

Review 8.  Drug resistance in human pathogenic fungi.

Authors:  K Iwata
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

9.  Fungicidal action of hydroxyl radicals generated by ultrasound in water.

Authors:  Atsuo Iwasawa; Keita Saito; Takayuki Mokudai; Masahiro Kohno; Toshihiko Ozawa; Yoshimi Niwano
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

Review 10.  Paracoccidioidomycosis: Current Perspectives from Brazil.

Authors:  Rinaldo Poncio Mendes; Ricardo de Souza Cavalcante; Sílvio Alencar Marques; Mariângela Esther Alencar Marques; James Venturini; Tatiane Fernanda Sylvestre; Anamaria Mello Miranda Paniago; Ana Carla Pereira; Julhiany de Fátima da Silva; Alexandre Todorovic Fabro; Sandra de Moraes Gimenes Bosco; Eduardo Bagagli; Rosane Christine Hahn; Adriele Dandara Levorato
Journal:  Open Microbiol J       Date:  2017-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.